185. J Colloid Interface Sci. 2018 May 15;518:122-129. doi:10.1016/j.jcis.2018.02.013. Epub 2018 Feb 7.Preparation of PLGA/Rose Bengal colloidal particles by double emulsion andlayer-by-layer for breast cancer treatment.Loya-Castro MF(1), Sánchez-Mejía M(1), Sánchez-Ramírez DR(2), Domínguez-RíosR(2), Escareño N(2), Oceguera-Basurto PE(2), Figueroa-Ochoa ÉB(3), Quintero A(2),Del Toro-Arreola A(2), Topete A(4), Daneri-Navarro A(5).Author information: (1)Unidad Académica de Ingeniería en Biotecnología, Universidad Politécnica deSinaloa, Mazatlán, Sinaloa 82199, Mexico.(2)Laboratorio de Inmunología, Departamento de Fisiología, Centro Universitariode Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950,Guadalajara, Jalisco 44340, Mexico.(3)Departamento de Química, Centro Universitario de Ciencias Exactas eIngenierías, Universidad de Guadalajara, Blv. Marcelino García Barragan 1421,Guadalajara, Jalisco 44430, Mexico.(4)Laboratorio de Inmunología, Departamento de Fisiología, Centro Universitariode Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950,Guadalajara, Jalisco 44340, Mexico. Electronic address:antonio.topete@cucs.udg.mx.(5)Laboratorio de Inmunología, Departamento de Fisiología, Centro Universitariode Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950,Guadalajara, Jalisco 44340, Mexico. Electronic address: daneri@cucs.udg.mx.The use of colloidal particles (CPs) in the transport of drugs is developingrapidly thanks to its effectiveness and biosafety, especially in the treatment ofvarious types of cancer. In this study Rose Bengal/PLGA CPs synthesized by doubleemulsion (W/O/W) and by electrostatic adsorption (layer-by-layer), werecharacterized and evaluated as potential breast cancer treatment. CPs wereevaluated in terms of size, zeta potential, drug release kinetics and cellviability inhibition efficacy with the triple negative breast cancer cell lineHCC70. The results showed that both types of CPs can be an excellent alternative to conventional cancer treatment by taking advantage of the enhanced permeationand retention (EPR) effect, manifested by solid tumors; however, the doubleemulsion CPs showed more suitable delivery times of up to 60% within two days,while layer-by-layer showed fast release of 50% in 90 min. Both types of CPs werecapable to decrease cell viability, which encourage us to further testing in invivo models to prove their efficacy and feasible use in the treatment of triplenegative breast cancer.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.jcis.2018.02.013 PMID: 29453102 